Bonesupport Holding AB (OSTO:BONEX) Short-Term Debt : kr0.0 Mil (As of Sep. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Bonesupport Holding AB Short-Term Debt?

Bonesupport Holding AB's Short-Term Debt for the quarter that ended in Sep. 2024 was kr0.0 Mil.

Bonesupport Holding AB Short-Term Debt Historical Data

The historical data trend for Bonesupport Holding AB's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bonesupport Holding AB Short-Term Debt Chart

Bonesupport Holding AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Debt

Get a 7-Day Free Trial

Bonesupport Holding AB Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Short-Term Debt	Get a 7-Day Free Trial															-	-	-	-	-

Bonesupport Holding AB Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Bonesupport Holding AB Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Bonesupport Holding AB's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Bonesupport Holding AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bonesupport Holding AB (OSTO:BONEX) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

BOEUF:USA 0RQO:UK 2B4:Germany

Address

Scheelevagen 19, Lund, SWE, SE-223 70

Website

https://www.bonesupport.com

Bonesupport Holding AB is a fast-growing ortho-biologics company that focuses on the treatment of bone disorders. The Company develops and sells injectable bio-ceramic bone graft substitutes based on its CERAMENT platform, which remodels to bone and has the ability to release pharmaceuticals to promote healing. Its products focus on trauma, revision arthroplasty (replacement of joint prostheses), chronic osteomyelitis (bone infection), and foot and ankle surgery. The Group manages and monitors operations in two operating segments: North America (NA) and Europe & Rest of the World (EUROW).

Bonesupport Holding AB Headlines

No Headlines